Skip to content
Review

Cortical lesions in multiple sclerosis: 25 years of progress, remaining challenges and future directions.

Sep 2026 · Nature Reviews Neurology · 0 citations · 104 references
Medicine

TL;DR

The neuropathological and imaging evidence linking cortical pathology to meningeal inflammation, neuroaxonal injury and progression independent of relapse activity is examined, and how emerging magnetic resonance imaging approaches for detecting and monitoring cortical lesions contribute to diagnosis and prognosis across the multiple sclerosis spectrum is assessed.

View source

Similar papers

Review Open access Sep 2026

Spinal cord imaging in multiple sclerosis: from diagnosis to disease progression

The characteristic MRI features of MS SC lesions and their key inflammatory and non-inflammatory differentials are described, and the role of SC imaging in diagnosis is examined, particularly in the context of the 2024 revisions to the McDonald criteria.

T. Koren, Jashan Dugal, Dong-Ang Wang et al. · 0 citations
Review Open access Sep 2026

Smoldering neuroinflammation in progressive multiple sclerosis: mechanisms, imaging biomarkers, and therapeutic opportunities

The pathological basis, imaging correlates, and therapeutic implications of smoldering neuroinflammation in progressive MS are discussed and current disease-modifying therapies incompletely control established chronic lesion biology are suggested.

Min Wang, Bo-Chi Zhu, Xi-Jing Mao · 0 citations
Review Open access Sep 2026

Management of Multiple Sclerosis: Incorporating Recent Advances in Pathophysiology and Diagnosis to Guide Treatment Strategies.

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disorder of the central nervous system for which more than 20 disease-modifying therapies (DMTs) are currently available. Recent advances in diagnostic criteria, biomarker development, and understanding of disease biology have challenged traditiona...

Moein Amin, Kaitlyn N. Palmer, A. Samara et al. · 0 citations
Sep 2026

Imaging subtypes reveal distinct biological substrates and disability profiles in multiple sclerosis.

Multimodal MRI analysed with SuStaIn identified reproducible subtypes of multiple sclerosis with clinically meaningful differences in phenotype, age at onset, disability, and relapse-independent progression, while cognitive impairment was related to advancing SuStaIn stage within each subtype.

P. Preziosa, L. Storelli, F. Clarelli et al. · 0 citations
Review Open access Aug 2026

Modern diagnosis and treatment of multiple sclerosis: advances, challenges, and future directions.

Key updates include expansion of dissemination in space to incorporate the optic nerve, integration of relapsing and progressive onset MS within a unified diagnostic framework, provision for diagnosis in selected asymptomatic individuals, dispensing with the requirement for dissemination of time in certain situations a...

P. Siriratnam, Mineesh Datta, Katherine A. Buzzard et al. · 0 citations
#diffusion models Open access Sep 2026

Chronic lesion expansion persists in secondary progressive multiple sclerosis and is associated with neurodegeneration

Chronic lesion expansion persists in SPMS and represents a major source of tissue injury associated with microstructural degeneration and brain atrophy and represents a major source of tissue injury associated with microstructural degeneration.

S. Klistorner, M. Barnett, A. Klistorner · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.